Cruz, Cita S.
HRN: 26-63-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/10/2025
02/17/2025
IV
4.5g Iv Drip Once Then 2.25g Q6hrs Iv Drip
Q6
CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Choice
Final appropriateness: Yes
Overall appropriateness: Yes